Telehealth

With 323 million seniors and a market set to hit ¥30 trillion, China's government is courting global innovators in elderly care. AID 2026 is the gateway.

The service commerce platform saw net income jump over 700% despite a drop in adjusted EBITDA, signaling a massive strategic bet on its AI-driven future.

Digital dentistry leader Medit acquires Progressive Orthodontics, launching a new division to merge high-tech scanning with world-class clinical training.

AmplifyMD wins 'Best Telemedicine Platform' for the second year. Discover how its AI-driven 'clinical operating system' is revolutionizing hospital care.

LifeMD posts record subscriber growth in Q1 driven by GLP-1 and women's health, but a planned loss from heavy marketing spend raises key questions.

The global wearable market is set to double, driven by a radical shift from simple step counters to sophisticated, AI-powered health monitoring tools.

Diathrive Health and AliveCor's KardiaComplete partner to offer an integrated solution for diabetes and heart disease, combating fragmented care and rising costs.

RVL Pharmaceuticals claims double-digit growth for its eye drop Upneeq, but as a private firm, its disruptive direct-to-consumer model operates outside public view.

Preclinical data for CITY-RBP4 shows promise in treating Stargardt disease, a leading cause of juvenile blindness with no approved therapies.

The Yashraj Bharati Samman honors two organizations transforming lives with a Rs. 1 Crore fund, shining a light on India's most impactful grassroots work.

Inworld AI launches Realtime TTS-2, a voice model with 'contextual empathy' that could revolutionize human-AI interaction, but also raises ethical questions.

A new AI platform uses patient simulations to train clinicians in tough end-of-life talks, promising more compassionate and consistent patient care.

The Sugar Ray Leonard Foundation's 15th annual charity boxing night will honor Dr. Jennifer Raymond for her groundbreaking work in pediatric diabetes care.

The Aesthetic Syndicate evolves into Manor, launching a national brand that fuses injectables with medically supervised GLP-1 therapy and holistic health.

As FDA rules on peptides shift, a new AI platform aims to give doctors clarity, separating solid science from speculation in the booming longevity market.

A landmark Canadian report finds 65% of mothers feel pressured to ignore childbirth trauma, exposing deep cracks in maternal physical and mental health care.

With a star-studded new advisory board, Pilatus Biosciences accelerates its attack on cancer's metabolic defenses with its lead drug, PLT012.

Beyond its first blockbuster, CRISPR Therapeutics reveals a deep pipeline for autoimmune and liver diseases, backed by a strong Q1 balance sheet.

A major investment in natural killer cell immunotherapy aims to revolutionize treatment for Canada's most fatal women's cancer after decades of stagnation.

A startup's partnership with industry giant Alcon promises to make vision assessment faster, more precise, and accessible to patients everywhere.